regorafenib 40 MG Oral Tablet [Stivarga]

RxCUI
1312408
RxNorm name
regorafenib 40 MG Oral Tablet [Stivarga]
Display name
regorafenib 40 MG Oral Tablet [Stivarga]
Full name
regorafenib 40 MG Oral Tablet [Stivarga]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:06

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
StivargaREGORAFENIBBayer HealthCare Pharmaceuticals Inc.824f19c9-0546-4a8a-8d8f-c4055c04f7c72026-02-09Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1312408

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
824f19c9-0546-4a8a-8d8f-c4055c04f7c7regorafenib 40 MG Oral Tablet [Stivarga]SBD36These highlights do not include all the information needed to use STIVARGA safely and effectively. See full prescribing information for STIVARGA. STIVARGA® (regorafenib) tablets, for oral use Initial U.S. Approval: 201220260209
824f19c9-0546-4a8a-8d8f-c4055c04f7c7Stivarga 40 MG Oral TabletSY36These highlights do not include all the information needed to use STIVARGA safely and effectively. See full prescribing information for STIVARGA. STIVARGA® (regorafenib) tablets, for oral use Initial U.S. Approval: 201220260209
824f19c9-0546-4a8a-8d8f-c4055c04f7c7Stivarga 40 MG Oral TabletPSN36These highlights do not include all the information needed to use STIVARGA safely and effectively. See full prescribing information for STIVARGA. STIVARGA® (regorafenib) tablets, for oral use Initial U.S. Approval: 201220260209